Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Phase 3
Completed
- Conditions
- Attention Deficit Hyperactivity DisorderADHD
- Interventions
- First Posted Date
- 2010-11-11
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Rhodes Pharmaceuticals, L.P.
- Target Recruit Count
- 230
- Registration Number
- NCT01239030
- Locations
- 🇺🇸
Center for Psychiatry and Behavioural Medicine Inc, Las Vegas, Nevada, United States
🇺🇸University of Cincinnati College of Medicine/PPSI, Cincinnati, Ohio, United States
🇺🇸Florida Clinical Research Center, LLC, Bradenton, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath